Conceivable

formerly Conceivable Life Sciences

The World's First AI-Powered Automated IVF Lab

New York, United States · Founded 2022 · $88.0M raised

Headquarters
New York, New York
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$88.0M
Last Round
$50.0M Series ASep 2025
Rounds
3

About

Conceivable Life Sciences is building the world's first AI-powered, fully automated IVF lab. Its flagship platform, AURA, automates all core IVF laboratory functions — including dish preparation, sperm processing, egg retrieval, ICSI, incubation, vitrification, and thawing — reducing human error and improving consistency. In an IRB-approved proof-of-concept study, AURA achieved 21 pregnancies with success rates comparable to the world's top-performing fertility clinics. The company's interdisciplinary team of 75+ medical doctors, scientists, and engineers is headquartered in New York with clinical operations in Mexico City.

Summary

Conceivable is a Healthcare company based in New York, United States, founded in 2022. It has raised $88.0M in total across 3 rounds, most recently a $50.0M Series A round in Sep 2025. Investors include ACME Capital, Advance Venture Partners and Stride.VC.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ASep 2025
$50.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies